Vermeire K - Search Results

1

Syntheses and anti-HIV and human cluster of differentiation 4 (CD4) down-modulating potencies of pyridine-fused cyclotriazadisulfonamide (CADA) compounds.

Lumangtad LA, Claeys E, Hamal S, Intasiri A, Basrai C, Yen-Pon E, Beenfeldt D, Vermeire K, Bell TW. Lumangtad LA, et al. Among authors: vermeire k. Bioorg Med Chem. 2020 Dec 15;28(24):115816. doi: 10.1016/j.bmc.2020.115816. Epub 2020 Oct 26. Bioorg Med Chem. 2020. PMID: 33181479 Free PMC article.

2

CADA inhibits human immunodeficiency virus and human herpesvirus 7 replication by down-modulation of the cellular CD4 receptor.

Vermeire K, Zhang Y, Princen K, Hatse S, Samala MF, Dey K, Choi HJ, Ahn Y, Sodoma A, Snoeck R, Andrei G, De Clercq E, Bell TW, Schols D. Vermeire K, et al. Virology. 2002 Oct 25;302(2):342-53. doi: 10.1006/viro.2002.1624. Virology. 2002. PMID: 12441078 Free article.

3

The Anti-HIV potency of cyclotriazadisulfonamide analogs is directly correlated with their ability to down-modulate the CD4 receptor.

Vermeire K, Bell TW, Choi HJ, Jin Q, Samala MF, Sodoma A, De Clercq E, Schols D. Vermeire K, et al. Mol Pharmacol. 2003 Jan;63(1):203-10. doi: 10.1124/mol.63.1.203. Mol Pharmacol. 2003. PMID: 12488553

4

Specific CD4 down-modulating compounds with potent anti-HIV activity.

Vermeire K, Schols D. Vermeire K, et al. J Leukoc Biol. 2003 Nov;74(5):667-75. doi: 10.1189/jlb.0403177. Epub 2003 Aug 1. J Leukoc Biol. 2003. PMID: 12960237 Review.

5

CD4 down-modulating compounds with potent anti-HIV activity.

Vermeire K, Schols D, Bell TW. Vermeire K, et al. Curr Pharm Des. 2004;10(15):1795-803. doi: 10.2174/1381612043384547. Curr Pharm Des. 2004. PMID: 15180541 Review.

6

CADA, a novel CD4-targeted HIV inhibitor, is synergistic with various anti-HIV drugs in vitro.

Vermeire K, Princen K, Hatse S, De Clercq E, Dey K, Bell TW, Schols D. Vermeire K, et al. AIDS. 2004 Nov 5;18(16):2115-25. doi: 10.1097/00002030-200411050-00003. AIDS. 2004. PMID: 15577644

7

Synthesis and structure-activity relationship studies of CD4 down-modulating cyclotriazadisulfonamide (CADA) analogues.

Bell TW, Anugu S, Bailey P, Catalano VJ, Dey K, Drew MG, Duffy NH, Jin Q, Samala MF, Sodoma A, Welch WH, Schols D, Vermeire K. Bell TW, et al. Among authors: vermeire k. J Med Chem. 2006 Feb 23;49(4):1291-312. doi: 10.1021/jm0582524. J Med Chem. 2006. PMID: 16480266 Free article.

8

Inhibitors of HIV infection via the cellular CD4 receptor.

Vermeire K, Schols D, Bell TW. Vermeire K, et al. Curr Med Chem. 2006;13(7):731-43. doi: 10.2174/092986706776055599. Curr Med Chem. 2006. PMID: 16611063 Review.

9

Design and cellular kinetics of dansyl-labeled CADA derivatives with anti-HIV and CD4 receptor down-modulating activity.

Vermeire K, Lisco A, Grivel JC, Scarbrough E, Dey K, Duffy N, Margolis L, Bell TW, Schols D. Vermeire K, et al. Biochem Pharmacol. 2007 Aug 15;74(4):566-78. doi: 10.1016/j.bcp.2007.05.018. Epub 2007 May 29. Biochem Pharmacol. 2007. PMID: 17603023

10

CADA, a potential anti-HIV microbicide that specifically targets the cellular CD4 receptor.

Vermeire K, Brouwers J, Van Herrewege Y, Le Grand R, Vanham G, Augustijns P, Bell TW, Schols D. Vermeire K, et al. Curr HIV Res. 2008 May;6(3):246-56. doi: 10.2174/157016208784324958. Curr HIV Res. 2008. PMID: 18473788

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

139 results

Search Page

Filters